Vivitrol Monthly Shot Approved for Opioid Dependence

The U.S. Food and Drug Administration has given the go-ahead to a once-monthly injection to treat opioid dependence, the agency said Tuesday. Vivitrol, a long-acting formulation of naltrexone (ReVia), is already approved as a monthly shot to treat alcohol dependence. The new indication puts Vivitrol on a list of pharmacologic treatments for addiction -- a list that already includes methadone and buprenorphine. "We are always happy to have another addition to our arsenal of addiction...Full Story
Commenting on this article is closed.